Clinical Trial Update: Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the safety and efficacy of STSP-0601 in adults with Hemophilia A or B with inhibitors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• STSP-0601 (STSP-0601)

Snippet

Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd | Conditions: Hemophilia | Phase 2 | Status: COMPLETED